Eisai America, Inc.
Basic information
- Head office
- 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan
- Chief executive
- Haruo Naito
- Capital
- 44,986 JPY
- Employees (non-consolidated)
- 2,998 people
- Employees (consolidated)
- 10,917 people
- Start date
- 1941-12-06
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
Network
History
Nihon Eisai Co., Ltd.'s contraceptive suppository : Sampoon : , researched and developed during Japan's postwar baby boom, receives official approval from the Japanese government.![]()
Nihon Eisai Co., Ltd. launches high-dosage vitamin B1 and B2 product : Chocola BB Tablets : in Japan.![]()
Eisai opens its Taipei Office (now part of Eisai Taiwan Inc.), the company's first overseas branch, in Taiwan.![]()
Gastrointestinal remedies : Saclon : and : Saclon Tablets : , recognizable for their distinct green hue even today, are launched in Japan.![]()
Toyoji Naito receives the Japan Marketing Award, which recognizes people who have made a significant contribution to marketing and advertising in Japan.![]()
A three-tier representative director system is introduced: Chairman Toyoji Naito, President Yuji Naito, and Executive Vice President Tatsuo Naito.![]()
PT Eisai Indonesia is established as a pharmaceutical manufacturing and sales subsidiary in Indonesia.![]()
Toyoji Naito resigns as representative director and chairman to assume director and honorary chairman roles.![]()
Toyoji opens the Naito Museum of Pharmaceutical Science and Industry, Japan's first pharmaceutical museum, in Gifu.![]()
Eisai (Malaysia) Sdn. Bhd. and Hi-Eisai Pharmaceutical Inc. are established as pharmaceutical sales subsidiaries in Malaysia and the Philippines, respectively.![]()
Eisai Asia Regional Services Pte. Ltd. is established as a sales support and management services subsidiary in Singapore.![]()
Eisai America, Inc. is established as a clinical research subsidiary in New Jersey, the United States.![]()
Eisai Inc. North Carolina Plant is established as a pharmaceutical manufacturing and formulation R&D facility at Research Triangle Park in North Carolina, the United States.![]()
Anti-Alzheimer's agent : Aricept : is launched in the United States, the United Kingdom and Germany.![]()
Eisai Medical Research Inc. is established as a clinical research subsidiary in New Jersey, the United States.![]()
Collaboration agreement with Biogen to develop and commercialize investigational Alzheimer's disease treatments including aducanumab expanded.![]()
Eisai agrees upon a strategic collaboration for Lenvima with Merck & Co., Inc., Kenilworth, N.J., U.S.A.![]()
Eisai Center for Genetics Guided Dementia Discovery (G2D2) in Massachusetts, U.S., commences full-scale operation.![]()
News
There is no news.